Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML
Clinical trial NCT05970822 · UNKNOWN
Trial details
- NCT number
- NCT05970822
- Sponsor
- Biocity Biopharmaceutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-18
- Primary completion
- 2025-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.